Cannabis use disorders part I: Pharmacology, epidemiology and therapy;Cannabisbezogene störungen teil I: Pharmakologie, epidemiologie und therapieverfahren

Fortschritte der Neurologie Psychiatrie

Volumn 78, Issue 5, 2010, Pages 297-305

  Bonnet, U ^a,b   Scherbaum, N ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE DEHYDROGENASE; ANANDAMIDE; ANTICONVULSIVE AGENT; ANXIOLYTIC AGENT; ATOMOXETINE; CANNABIDIOL; CANNABINOID; CANNABINOID 1 RECEPTOR; CANNABINOL; CANNABIS; CYTOCHROME P450 2C19; CYTOCHROME P450 2C9; CYTOCHROME P450 3A4; DOPAMINE; DRONABINOL; ENDOCANNABINOID; ILLICIT DRUG; NEUROLEPTIC AGENT; OPIATE; RIMONABANT; TERPENE DERIVATIVE; TETRAHYDROCANNABINOL;

ABSTINENCE; CANNABIS ADDICTION; CEREBELLUM; COGNITION; COMORBIDITY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG USE; EMOTIONALITY; FAMILY THERAPY; FEAR; GENETIC POLYMORPHISM; GERMANY; HALF LIFE TIME; HIPPOCAMPUS; HUMAN; INHALATION; INTERNET; LEARNING; LIMBIC CORTEX; NICOTINE REPLACEMENT THERAPY; NUCLEUS ACCUMBENS; PSYCHOTHERAPY; REMISSION; REVIEW; RISK FACTOR; SUBSTANCE ABUSE; SYNAPSE; URINALYSIS; URINARY EXCRETION; WITHDRAWAL SYNDROME; ADOLESCENT; ADULT; DRUG ANTAGONISM; DRUG EFFECT; FEMALE; MALE; METABOLISM; MIDDLE AGED;

ADOLESCENT; ADULT; CANNABIS; DOPAMINE; FEMALE; HUMANS; MALE; MARIJUANA ABUSE; MIDDLE AGED; NUCLEUS ACCUMBENS; PSYCHOTHERAPY; TETRAHYDROCANNABINOL; YOUNG ADULT;

EID: 77951681986     PISSN: 07204299     EISSN: 14393522     Source Type: Journal    
DOI: 10.1055/s-0029-1245212     Document Type: Review

References (29)

1. Bonnet U, Scherbaum N. Evidenzbasierte Behandlung der Cannabisabhängigkeit. Backmund M Suchtherapie Landsberg Ecomed 2007 1-28
2. Kraus L, Pfeiffer-Gerschel T, Pabst A. Cannabis und andere illegale Drogen: Prävalenz, Konsummuster und Trends. Ergebnisse des Epidemiologischen Suchtsurveys 2006. Sucht 2008 54 (1) S16-S56
3. Drogen- und Suchtbericht 2009. Bundesministerium für Gesundheit http://www.bmg.bund.de/SharedDocs/Downloads/DE/Drogen-Sucht/drogen-und- suchtbericht2009,templateId = raw,property = publicationFile.pdf/drogen-und- suchtbericht2009.pdf; Stand: 18.1.10
4. Orth B, Kraus L. Illegale Drogen Zahlen und Fakten zum Konsum. DHS Jahrbuch Sucht 09 Geesthacht Neuland Verlagsgesellschaft 2009 99-111
5. Brenneisen R. Pharmakokinetik. Grotenhermen F Cannabis und Cannabinoide Bern Huber 2001 87-107
6. Huestis M A. Human Cannabinoid Pharmacokinetics. Chem Biodivers 2007 4 1770-1804
7. Grauwiler S B., Drewe J, Scholer A. Sensitivity and specifity of urinary cannabinoid detection with two immunoassays after controlled oral administration of delta-9-tetrahydrocannabinol to humans. Ther Drug Monit 2008 30 1114-1124
8. Dasgupta A. The effects of adulterants and selected ingested compounds on drugs-of-abuse testing in urine. Am J Clin Pathol 2007 128 491-503 (Pubitemid 47479983)
9. Bonnet U, Harries-Hedder K, Leweke F M. et al. AWMF-Leitlinie: Cannabis-bezogene Störungen. Fortschr Neurol Psychiatrie 2004 72 318-329
10. Daldrup T, Käferstein H, Köhler H et al. Entscheidung zwischen einmaligem/ gelegentlichen und regelmäigen Cannabiskonsum. Blutalkohol 2000 37 39-47 (Pubitemid 30046407)
11. Musshoff F, Madea B. Review of biologic matrices (urine, blood, hair) as indicators of recent or ongoing cannabis use. Ther Drug Monit 2006 28 155-163 (Pubitemid 44314942)
12. Wegener N, Schneider M, Koch M. Das endocannabinoide System des Gehirns von der Neurobiologie zur klinischen Relevanz. Neuroforum 2008 4 256-267
13. Perkonigg A, Lieb R, Höfler M et al. Patterns of cannabis use, abuse and dependence over time: incidence, progression and stability in a sample of 1228 adolescents. Addiction 1999 94 1663-1678
14. Dennis M, Titus J C., Diamond G et al. The Cannabis Youth Treatment (CYT) experiment: rationale, study design and analysis plans. Addiction 2002 97 (Suppl 1) 6-34
15. Swift W, Hall W, Teesson M. Characteristics of DSM-IV and ICD-10 cannabis dependence among Australian adults: results from a national survey of mental health and wellbeing. Drug Alcohol Depend 2001 63 147-153 (Pubitemid 32488929)
16. McRae A L., Budney A J., Brady K T. Treatment of marijuana dependence: a review of literature. JSubst Abuse Treat 2003 24 369-376 (Pubitemid 36809291)
17. Zumdick S, Schneider U, Leweke F M. et al. Studienlage zur Behandlung der Cannabisabhängigkeit. Fortschr Neurol Psychiatrie 2006 73 1-15
18. Dennis M, Godley S H., Diamond G et al. The Cannabis Youth Treatment (CYT) Study: Main findings from two randomized trials. JSubst Abuse Treat 2004 27 197-213 (Pubitemid 40292028)
19. Liddle H A., Dakof G A., Turner R M. et al. Treating adolescent drug abuse: a randomized trial comparing multidimensional family therapy and cognitive behaviour therapy. Addiction 2008 103 1660-1670
20. Budney A J., Moore B, Rocha H L. et al. Clinical trial of abstinence-based vouchers and cognitive-behavioral therapy for cannabis dependence. JConsult Clin Psychology 2006 74 307-316 (Pubitemid 43807362)
21. Carroll K M., Easton C J., Nich C. The use of contingency management and morivational/skills-building therapy to treat young adults with marijuana dependence. JConsult Clin Psychology 2006 74 955-966 (Pubitemid 44547489)
22. Kadden R M., Litt M D., Kabela-Cormier E et al. Abstinence rates following behavioral treatments for marijuana dependence. Addict Behav 2007 32 1220-1236 (Pubitemid 46497550)
23. Hoch E, Noack R, Rohrbacher H et al. Gezielte Behandlung von Cannabisstörungen das modulare, kognitiv-behaviorale Entwö hnungprogramm CANDIS. Sucht Aktuell 2007 2 57-59
24. Perkonigg A, Rumpf H -J, Wittchen H -U. Remission from substance dependence without formal help among adulescents and young adults. Sucht 2009 55 86-97
25. Perkonigg A, Goodwin R D., Fiedler A et al. The natural course of cannabis use, abuse and dependence during the first decades of life. Addiction 2008 103 439-449 (Pubitemid 351208093)
26. Benyamina A, Lecacheux M, Blecha L et al. Pharmacotherapy and psychotherapy in cannabis withdrawal and dependence. Expert Rev Neurother 2008 8 479-491
27. Tirado C F., Goldman M, Lynch K et al. Atomoxetine for treatment of marijuana dependence: a report on the efficacy and high incidence of gastrointestinal events in a pilot study. Drug Alcohol Depend 2008 94 254-257
28. Huestis M A., Boyd S J., Heishman S J. Single and multiple doses of rimonabant antagonize acute effects of smoked cannabis in male cannabis users. Psychopharmacol 2007 194 505-515
29. Levin F R., Kleber H D. Use of dronabinol for cannabis dependence: two case reports and review. Am J Addict 2008 17 161-164